COVID-19 antibody research study

Falck conducts COVID-19 research study

In early 2020, COVID-19 appeared in our lives. Data is needed to inform decisions on how to better protect ourselves, our employees and society in general.

Falck is an employer of approximately 30,000 employees and an integral part of national healthcare systems' response to the COVID-19 pandemic. Communities rely our employees and our employees rely on Falck to meet health and saftey requirements.

We have set out to gain knowledge of how the virus spreads in order to assess which measures to take to protect healthcare employees and the surrounding society. Being a research study with up to 4,000 Falck employees in Denmark and Sweden participating, the study is to inform our decisions in Falck. In addition, it is a research asset to society at large. We will publish interim results during the project in order to use the new knowledge as quickly as possible

The research study is sponsored by the Lundbeck Foundation.

Read more

News

8 July 2020 First COVID-19 study results confirm correlation
between frequent patient contact and antibodies. Read more

Meet the people behind our research study

President and CEO Jakob Riis and Professor Henrik Ullum explain why the research project has value for both the participants, our company and society in general. Research Officer Jannie Laursen demonstrates how the antibody test works and explains what information we gain from the antibody tests.

Methodology

The methodology has been approved by the Danish National Committee on health research ethics (NVK). Download a presentation of the methodology and research design (PDF).

Read more

Q & A

Contact

Research responsible

Jannie Laursen

Email: jannie.laursen@falck.com
Send email

Explore further